Impairment charge in respect of Danisco Sugar A/S
Both the spin-off and sale processes are progressing according to plan, and we will provide an update on 23 June 2008 in conjunction with our full-year results.
Danisco A/S is required to perform impairment tests of the value of its assets. In light of the planned spin-off or the potential sale of Danisco Sugar A/S, and in conjunction with its advisers, Danisco A/S now expects to book a goodwill impairment charge in regard to its Sugar division of between DKK 0.5-1.0 billion. Following this impairment charge the Invested Capital of the Sugar division at the end of April 2008 was between DKK 6.2-6.7 billion.
This book impairment charge will be recorded under special items in the financial statements in the fourth quarter for the financial year ending 30 April 2008.
Danisco therefore expects profit for the year before share-based payments of between DKK 0.6 and 1.1 billion for the financial year ended 30 April 2008.
The results for 2007/08 will be announced on 23 June 2008.
Danisco Deutschland GmbH
With a rich and innovative portfolio, Danisco is a world leader in food ingredients, enzymes and bio-based solutions. Using nature's own materials, science and the knowledge of our 9,500 people, we design and deliver bio-based ingredients that meet market demand for healthier and safer products. Danisco's ingredients are used globally in a wide range of industries
- from bakery, dairy and beverages to animal feed, laundry detergents and bioethanol - offering functional, economic and environmental benefits. Headquartered in Denmark and operating from more than 120 locations, Danisco's key focus is to become our customers' First choice and a truly market-driven global business. In addition, we have one of the most efficient sugar production platforms in Europe. Find out more at www.danisco.com